Thomas J C Ward1, Charles D Plumptre2, Thomas E Dolmage3, Amy V Jones4, Ruth Trethewey4, Pip Divall5, Sally J Singh6, Martin R Lindley7, Michael C Steiner6, Rachael A Evans8. 1. National Centre for Sport and Exercise Medicine, Loughborough University, Loughborough, United Kingdom; Centre for Exercise & Rehabilitation Science, Leicester Biomedical Research Centre-Respiratory, Glenfield Hospital, Leicester, United Kingdom; Department of Respiratory Medicine, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom. 2. School of Medicine, University of Oxford, Oxford, United Kingdom. 3. Respiratory Diagnostic & Evaluation Services, West Park Healthcare Centre, Toronto, ON, Canada. 4. National Centre for Sport and Exercise Medicine, Loughborough University, Loughborough, United Kingdom; Centre for Exercise & Rehabilitation Science, Leicester Biomedical Research Centre-Respiratory, Glenfield Hospital, Leicester, United Kingdom. 5. Department of Respiratory Medicine, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom. 6. National Centre for Sport and Exercise Medicine, Loughborough University, Loughborough, United Kingdom; Centre for Exercise & Rehabilitation Science, Leicester Biomedical Research Centre-Respiratory, Glenfield Hospital, Leicester, United Kingdom; Department of Respiratory Medicine, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom; Department of Respiratory Science, University of Leicester, Leicester, United Kingdom. 7. National Centre for Sport and Exercise Medicine, Loughborough University, Loughborough, United Kingdom; Translational Cell Biology Research Group, Loughborough University, Loughborough, United Kingdom. 8. National Centre for Sport and Exercise Medicine, Loughborough University, Loughborough, United Kingdom; Centre for Exercise & Rehabilitation Science, Leicester Biomedical Research Centre-Respiratory, Glenfield Hospital, Leicester, United Kingdom; Department of Respiratory Medicine, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom; Department of Respiratory Science, University of Leicester, Leicester, United Kingdom. Electronic address: re66@le.ac.uk.
Abstract
BACKGROUND: Despite the wide-ranging benefits of pulmonary rehabilitation, conflicting results remain regarding whether people with COPD can improve their peak oxygen uptake (V˙O2peak) with aerobic training. RESEARCH QUESTION: The goal of this study was to investigate the effect of aerobic training and exercise prescription on V˙O2peak in COPD. STUDY DESIGN AND METHODS: A systematic review was performed by using MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, and Cochrane databases for all studies measuring V˙O2peak prior to and following supervised lower-limb aerobic training in COPD. A random effects meta-analysis limited to randomized controlled trials comparing aerobic training vs usual care was conducted. Other study designs were included in a secondary meta-analysis and meta-regression to investigate the influence of program and patient factors on outcome. RESULTS: A total of 112 studies were included (participants, N = 3,484): 21 controlled trials (n = 489), of which 13 were randomized (n = 288) and 91 were uncontrolled (n = 2,995) studies. Meta-analysis found a moderate positive change in V˙O2peak (standardized mean difference, 0.52; 95% CI, 0.34-0.69) with the intervention. The change in V˙O2peak was positively associated with target duration of exercise session (P = .01) and, when studies > 1 year duration were excluded, greater total volume of exercise training (P = .01). Similarly, the change in V˙O2peak was greater for programs > 12 weeks compared with those 6 to 12 weeks when adjusted for age and sex. However, reported prescribed exercise intensity (P = .77), training modality (P > .35), and mode (P = .29) did not affect V˙O2peak. Cohorts with more severe airflow obstruction exhibited smaller improvements in V˙O2peak (P < .001). INTERPRETATION: Overall, people with COPD achieved moderate improvements in V˙O2peak through supervised aerobic training. There is sufficient evidence to show that programs with greater total exercise volume, including duration of exercise session and program duration, are more effective. Reduced effects in severe disease suggest alternative aerobic training methods may be needed in this population. CLINICAL TRIAL REGISTRATION: PROSPERO; No.: CRD42018099300; URL: https://www.crd.york.ac.uk/prospero/.
BACKGROUND: Despite the wide-ranging benefits of pulmonary rehabilitation, conflicting results remain regarding whether people with COPD can improve their peak oxygen uptake (V˙O2peak) with aerobic training. RESEARCH QUESTION: The goal of this study was to investigate the effect of aerobic training and exercise prescription on V˙O2peak in COPD. STUDY DESIGN AND METHODS: A systematic review was performed by using MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, and Cochrane databases for all studies measuring V˙O2peak prior to and following supervised lower-limb aerobic training in COPD. A random effects meta-analysis limited to randomized controlled trials comparing aerobic training vs usual care was conducted. Other study designs were included in a secondary meta-analysis and meta-regression to investigate the influence of program and patient factors on outcome. RESULTS: A total of 112 studies were included (participants, N = 3,484): 21 controlled trials (n = 489), of which 13 were randomized (n = 288) and 91 were uncontrolled (n = 2,995) studies. Meta-analysis found a moderate positive change in V˙O2peak (standardized mean difference, 0.52; 95% CI, 0.34-0.69) with the intervention. The change in V˙O2peak was positively associated with target duration of exercise session (P = .01) and, when studies > 1 year duration were excluded, greater total volume of exercise training (P = .01). Similarly, the change in V˙O2peak was greater for programs > 12 weeks compared with those 6 to 12 weeks when adjusted for age and sex. However, reported prescribed exercise intensity (P = .77), training modality (P > .35), and mode (P = .29) did not affect V˙O2peak. Cohorts with more severe airflow obstruction exhibited smaller improvements in V˙O2peak (P < .001). INTERPRETATION: Overall, people with COPD achieved moderate improvements in V˙O2peak through supervised aerobic training. There is sufficient evidence to show that programs with greater total exercise volume, including duration of exercise session and program duration, are more effective. Reduced effects in severe disease suggest alternative aerobic training methods may be needed in this population. CLINICAL TRIAL REGISTRATION: PROSPERO; No.: CRD42018099300; URL: https://www.crd.york.ac.uk/prospero/.
Authors: Suhani Patel; Melanie D Palmer; Claire Marie Nolan; Ruth Emily Barker; Jessica Anne Walsh; Stephanie C Wynne; Sarah Elizabeth Jones; Harriet Shannon; Nicholas S Hopkinson; Samantha Swee Chin Kon; Wei Gao; Matthew Maddocks; William D-C Man Journal: Thorax Date: 2020-11-01 Impact factor: 9.139
Authors: Thomas Hess; Markus Wirz; Anne-Kathrin Rausch Osthoff; Swantje Beyer; David Gisi; Spencer Rezek; Ariane Schwank; André Meichtry; Noriane A Sievi Journal: BMC Pulm Med Date: 2021-10-12 Impact factor: 3.317
Authors: Karin Vonbank; Antje Lehmann; Dominik Bernitzky; Maximilian Robert Gysan; Stefan Simon; Pavla Krotka; Ralf-Harun Zwick; Marco Idzko; Martin Burtscher Journal: Scand J Med Sci Sports Date: 2021-12-26 Impact factor: 4.645
Authors: Sara C Buttery; Adam Lewis; Samuel V Kemp; Winston Banya; Jennifer K Quint; Michael C Steiner; Nicholas S Hopkinson Journal: BMJ Open Date: 2020-11-27 Impact factor: 2.692